MedTrace Logo

CoolSculpting of the Distal Thigh Study

NCT02335749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-12-01

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using a small area applicator for non-invasive subcutaneous fat reduction in the distal thigh.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

The ZELTIQ System

The CoolSculpting System with a Small Area Applicator will be used to deliver treatments.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-17
Primary Completion
2015-11-09
Completion
2015-11-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335749 on ClinicalTrials.gov